Stéphane Bardet

6.4k total citations · 1 hit paper
90 papers, 3.3k citations indexed

About

Stéphane Bardet is a scholar working on Endocrinology, Diabetes and Metabolism, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Stéphane Bardet has authored 90 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Endocrinology, Diabetes and Metabolism, 42 papers in Radiology, Nuclear Medicine and Imaging and 23 papers in Surgery. Recurrent topics in Stéphane Bardet's work include Thyroid Cancer Diagnosis and Treatment (43 papers), Medical Imaging Techniques and Applications (25 papers) and Radiopharmaceutical Chemistry and Applications (13 papers). Stéphane Bardet is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (43 papers), Medical Imaging Techniques and Applications (25 papers) and Radiopharmaceutical Chemistry and Applications (13 papers). Stéphane Bardet collaborates with scholars based in France, Luxembourg and Italy. Stéphane Bardet's co-authors include Nicolas Aide, M. Henry‐Amar, Jean-Pierre Rame, Pierre Véra, Renaud Ciappuccini, Martin Schlumberger, Yves Reznik, Natacha Heutte, Jacques Barbet and Claire Schvartz and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Stéphane Bardet

86 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer

2012 448 citations Martin Schlumberger, Bogdan Catargi et al. profile →

Peers

Countries citing papers authored by Stéphane Bardet

Since Specialization

Citations

This map shows the geographic impact of Stéphane Bardet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Bardet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Bardet more than expected).

Fields of papers citing papers by Stéphane Bardet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Bardet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Bardet. The network helps show where Stéphane Bardet may publish in the future.

Co-authorship network of co-authors of Stéphane Bardet

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane Bardet. A scholar is included among the top collaborators of Stéphane Bardet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane Bardet. Stéphane Bardet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patients with medullary thyroid carcinoma and long term treatment with vandetanib: a study from the endocan -tuthyref network 2024 ·Endocrine Abstracts ·Hélène Lasolle, Livia Lamartina, (unknown), Camille Buffet, Olivier Schneegans, (unknown), D. Drui, Danielle Benisvy, (unknown), Yann Godbert, Stéphane Bardet, Marie Batisse‐Lignier, C. Chougnet, Slimane Zerdoud, Nathalie Roudaut, F. Illouz, Christophe Sajous, Julien Hadoux, (unknown), Françoise Borson‐Chazot	1
2	Artificial intelligence solution to accelerate the acquisition of MRI images: Impact on the therapeutic care in oncology in radiology and radiotherapy departments 2024 ·Cancer/Radiothérapie ·R Lemaire, (unknown), (unknown), Cyril Jaudet, (unknown), (unknown), (unknown), (unknown), Alexis Lechervy, Joëlle Lacroix, (unknown), Stéphane Bardet, Juliette Thariat, (unknown), (unknown)	3
3	Deep Learning Denoising Improves and Homogenizes Patient [18F]FDG PET Image Quality in Digital PET/CT 2023 ·Diagnostics ·(unknown), Elske Quak, Idlir Licaj, Renaud Ciappuccini, Charline Lasnon, Aurélien Corroyer‐Dulmont, (unknown), Stéphane Bardet, Cyril Jaudet	3
4	Artificial intelligence-based PET denoising could allow a two-fold reduction in [18F]FDG PET acquisition time in digital PET/CT 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Charline Lasnon, Renaud Ciappuccini, (unknown), Aurélien Corroyer‐Dulmont, Elske Quak, Bénédicte Clarisse, (unknown), Stéphane Bardet, Cyril Jaudet	32
5	Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment 2022 ·British Journal of Cancer ·(unknown), Carolé Rubino, Rodrigue S. Allodji, (unknown), Stéphane Bardet, Ibrahima Diallo, Massimo E. Dottorini, (unknown), Per Hall, M. Henry‐Amar, Stéphanie Lamart, (unknown), Stefan Lönn, Marcel Ricard, Claire Schvartz, Martin Schlumberger, Neige Journy, Florent de Vathaire	5
6	Génotypage moléculaire dans les cancers réfractaires de la thyroïde en 2021 : quand, comment, et pourquoi ? Un travail du réseau TUTHYREF 2021 ·Bulletin du Cancer ·Christelle de la Fouchardière, Johanna Wassermann, Fabien Calcagno, Stéphane Bardet, Abir Al Ghuzlan, Isabelle Borget, Françoise Borson‐Chazot, Christine Do Cao, Camille Buffet, Slimane Zerdoud, Myriam Decaussin‐Petrucci, Yann Godbert, Sophie Leboulleux	8
7	Radioimmunotherapy for Brain Metastases: The Potential for Inflammation as a Target of Choice 2021 ·Frontiers in Oncology ·Aurélien Corroyer‐Dulmont, Cyril Jaudet, (unknown), (unknown), (unknown), Katherine A. Vallis, Nadia Falzone, Nicola R. Sibson, Michel Chérel, Françoise Kraeber‐Bodéré, A. Batalla, Stéphane Bardet, Myriam Bernaudin, Samuel Valable	4
8	Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer 2014 ·EJNMMI Research ·Pierre Véra, Bernard Dubray, (unknown), Irène Buvat, Sébastien Hapdey, Romain Modzelewski, Ahmed Benyoucef, Caroline Rousseau, Marc-Étienne Meyer, Stéphane Bardet, Isabelle Gardin, Frédéric Di Fiore, Pierre Michel	16
9	The predictive value of treatment response using FDG PET performed on day 21 of chemoradiotherapy in patients with oesophageal squamous cell carcinoma. A prospective, multicentre study (RTEP3) 2013 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Pierre Michel, Jean-François Ménard, Caroline Rousseau, Emmanuel Rio, B. Bridji, Ahmed Benyoucef, Marc-Étienne Meyer, (unknown), Stéphane Bardet, (unknown), Philippe Olivier, (unknown), Emmanuel Itti, (unknown), C. Houzard, F. Mornex, Frédéric Di Fiore, Pierre Véra	36
10	F18-Choline, a Novel PET Tracer for Parathyroid Adenoma? 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Elske Quak, Stéphanie Lheureux, Yves Reznik, Stéphane Bardet, Nicolas Aide	59
11	Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement 2012 ·Journal of Nuclear Medicine ·Pierre‐Yves Salaün, L. Campion, Claire Bournaud, Alain Faivre-Chauvet, Jean‐Philippe Vuillez, David Taïeb, C. Ansquer, Caroline Rousseau, Françoise Borson‐Chazot, Stéphane Bardet, A. Oudoux, Bertrand Cariou, Éric Mirallié, Chien‐Hsing Chang, Robert M. Sharkey, David M. Goldenberg, Jean‐François Chatal, Jacques Barbet, Françoise Kraeber‐Bodéré	44
12	SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma 2011 ·Blood ·Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, Anne Julian, Catherine Thiéblemont, Pierre Véra, Serge Bologna, Josette Brière, Jean-Philippe Jaı̈s, Corinne Haïoun, Bertrand Coiffier, Franck Morschhauser	216
13	Interim [ ¹⁸ F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab 2011 ·Journal of Clinical Oncology ·Violaine Safar, Jehan Dupuis, Emmanuel Itti, Fabrice Jardin, Christophe Fruchart, Stéphane Bardet, Pierre Véra, Christiane Copie‐Bergman, Alain Rahmouni, Hervé Tilly, Michel Meignan, Corinne Haïoun	124
14	Comparison of four strategies of radioiodine ablation in patients with thyroid cancer with low-risk of recurrence: the randomized, prospective ESTIMABL study 2011 ·Laurence Leenhardt, Bogdan Catargi, Isabelle Borget, Slimane Zerdoud, B. Bridji, Stéphane Bardet, Marie‐Elisabeth Toubert, M Schlumberger	3
15	Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography for Interim Response Assessment of Advanced-Stage Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review 2009 ·Journal of Clinical Oncology ·Teruhiko Terasawa, Joseph Lau, Stéphane Bardet, Olivier Couturier, Tomomitsu Hotta, Martin Hutchings, Takashi Nihashi, (unknown)	188
16	Early 2′-Deoxy-2′-[18F]Fluoro-d-Glucose PET Metabolic Response after Corticosteroid Therapy to Differentiate Cancer from Sarcoidosis and Sarcoid-like Lesions 2009 ·Molecular Imaging and Biology ·Nicolas Aide, Djelila Allouache, Yann Ollivier, (unknown), O. Switsers, Stéphane Bardet	22
17	Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study 2008 ·European Journal of Endocrinology ·C. Fagour, Stéphane Bardet, V. Rohmer, Yannick Arimone, Pierre Lecomte, Nathalie Valli, Antoine Tabarin	48
18	Clinical impact of fluorine-18 fluorodeoxyglucose positron emission tomography in cancer patients. A comparative study between dedicated camera and dual-head coincidence gamma camera. 2006 ·PubMed ·(unknown), O. Switsers, (unknown), Jimmy Jacob, T. Delozier, (unknown), (unknown), (unknown), M. Henry‐Amar, Stéphane Bardet	2
19	High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer 2005 ·The Journal of Clinical Endocrinology & Metabolism ·Éric Mirallié, J.-P. Vuillez, Stéphane Bardet, Éric Frampas, (unknown), Ludovic Ferrer, Alain Faivre-Chauvet, A. Murat, B Charbonnel, Jacques Barbet, David M. Goldenberg, J.F. Chatal, Françoise Kraeber‐Bodéré	49
20	Densité minérale osseuse et marqueurs biologiques de remaniement osseux chez des patients porteurs d’incidentalome surrénalien : effet d’un hypercortisolisme infraclinique 2002 ·La Revue de Médecine Interne ·Stéphane Bardet, V. Rohmer, F Casson, Christine Coffin, (unknown), Julia Sabatier, Philippe Lecomte, Maurice Audran, M. Henry‐Amar, Antoine Tabarin	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact